• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: HALYARD - IRVINE ON-Q C-BLOC 400ML, 2-14ML/HR SELECT-A-FLOW; ELASTOMERIC PUMP

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

HALYARD - IRVINE ON-Q C-BLOC 400ML, 2-14ML/HR SELECT-A-FLOW; ELASTOMERIC PUMP Back to Search Results
Model Number CB004
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Sepsis (2067); Tachycardia (2095); Blurred Vision (2137); Chills (2191); Anxiety (2328)
Event Date 12/16/2014
Event Type  Injury  
Event Description
Fill volume: 500ml.Flow rate: 10ml/hr.Procedure: robotic colectomy.Cathplace: tap.Please reference: 2026095-2015-00004/(b)(4).Pump #1 of 2.A pt reported experiencing worsening of symptoms from local anesthetic while using 2 pumps.The pt experienced several episode of chills, blurred vision, increased heart rate (hr), and anxiety while in the hosp.The infusion began at that time with unspecified pumps.The symptoms were intermittent (not constant) while hospitalized.The pt stated that different devices were used at facility to infuse anesthetic.On (b)(6) 2014, the on-q pumps were placed prior to discharge.Upon discharge, the side effects became constant and worsened.The pt was treated with an unspecified anti-anxiety medication; however, the symptoms did not resolve after taking the medication.It was reported that the pt experienced the symptoms for 3 days at various times.The pt was instructed to clamp the pumps and notify the surgeon.The pt followed up with the physician who instructed the pt to remove the pumps.The infusion ended at that time on (b)(6) 2014.Upon removal, the pumps were not empty and contained most of the medication.Within the hr, the symptoms subsided.The device was saved for return.
 
Manufacturer Narrative
Method: the device was reported to be returning for an eval and at this time is pending return.A review of the device history record (dhr) is in progress for the reported lot number.Results: at this time, halyard is pending the receipt of the device and as the investigation is still in progress, results are not available.Once the device is received, testing will be performed and results will be provided upon completion.Conclusions: once the investigation and device analysis are completed, a f/u report will be submitted.Info from this incident has been included in our product complaint and mdr trend reporting systems.Trend info is used to identify the need for add'l investigations.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ON-Q C-BLOC 400ML, 2-14ML/HR SELECT-A-FLOW
Type of Device
ELASTOMERIC PUMP
Manufacturer (Section D)
HALYARD - IRVINE
irvine CA
Manufacturer Contact
maria wagner
43 discovery
ste 100
irvine, CA 92618
9499232324
MDR Report Key4420696
MDR Text Key5377836
Report Number2026095-2015-00003
Device Sequence Number1
Product Code MEB
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K063530
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Consumer,Health Professional,Company Representative
Reporter Occupation Not Applicable
Type of Report Initial
Report Date 12/18/2014
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received01/13/2015
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date01/31/2016
Device Model NumberCB004
Device Catalogue Number101347200
Device Lot Number0201097945
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? No
Date Manufacturer Received12/18/2014
Was Device Evaluated by Manufacturer? No
Date Device Manufactured08/01/2013
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
DRUG: ROPIVACAINE 0.1%; TYLENOL 2 TABLETS
Patient Outcome(s) Required Intervention;
Patient Age63 YR
Patient Weight91
-
-